PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31615744-5	2020	When comparing the changes in CyPA before and after BPA in the two subgroups with higher (>=35pg/mL) and normal (<35pg/mL) BNP at baseline, CyPA decreased both in patients with higher BNP and those with normal BNP (both p< 0.05).	bisphenol A	52-55	peptidylprolyl isomerase A	Homo sapiens	140-144	
31615744-8	2020	CONCLUSIONS: CyPA could be a useful biomarker to evaluate the effects of BPA even in patients with normal BNP or high BMI.	bisphenol A	73-76	peptidylprolyl isomerase A	Homo sapiens	13-17